Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management
DOI :
https://doi.org/10.20513/2447-6595.2017v57n3p54-57Mots-clés :
Uveitis. Birdshot chorioretinopathy. HLA-A29. Retinal vasculitis. Anti-inflammatory agents.Résumé
Birdshot chorioretinopathy is an organ-specific, potentially blinding chronic of bilateral inflammation of the posterior eye segment. It is seen mainly in persons who have the HLA-A29 haplotype. The diagnosis remains clinical and is based in his hallmark, which is the presence of multiples white dots throughout the fundus, resembling a shotgun pattern. The immune mechanisms involved in its pathogenesis remains unclear and the long-term outcome is guarded. However, the use of immunosuppressive agents and newer therapies demonstrated control of the inflammation and is a hope mainly in refractory cases. We report a case of Birdshot chorioretinopathy treated successfully with steroids and immunosuppressive agents.Téléchargements
Les données relatives au téléchargement ne sont pas encore disponibles.
Téléchargements
Publiée
2017-12-04
Numéro
Rubrique
RELATOS DE CASO